Previous Close | 2.5432 |
Open | 2.4700 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 2.5432 - 2.5432 |
52 Week Range | 1.6800 - 3.8100 |
Volume | |
Avg. Volume | 288 |
Market Cap | 3.052M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 82.04 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Company Acquiring Clinic in New HampshireLOS ANGELES, May 16, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has entered into a binding agreement to acquire the assets of New England Ketamine PLLC (“NEK”), a healthcare clinic in Salem, New Hampshire. Klee Irwin, CEO, said, “Adding another EBITDA positive ketamine clinic to our expanding footprint positions us well for accelerated growth of profitability. With over 10
LOS ANGELES, May 13, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it has entered into an agreement through its wholly owned subsidiary Irwin Naturals Cannabis, Inc., with Assurance Laboratories, LLC (“Assurance”), a New Mexico based manufacturer and distributor of cannabis products, pursuant to which Assurance will license the Irwin Naturals brand, and will produce and distribute Irwin Naturals’ famous formulas, such
Conference Call on Tuesday, May 3, 2022 at 2:00pm ESTLOS ANGELES, May 03, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today announced the Company will file its results for the fiscal fourth quarter and full year 2021, the period ended December 31, 2021, on Tuesday May 3, 2022 on www.sedar.com. Conference call CEO Klee Irwin and CFO Philippe Faraut will be hosting a conference call that same day at noon (EST) to discuss the results,